𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Theory-based analysis of anti-inflammatory effect of infliximab on Crohn’s disease and rheumatoid arthritis

✍ Scribed by Koji Kimura; Risa Takayanagi; Haruko Yokoyama; Yasuhiko Yamada

Publisher
Springer
Year
2010
Tongue
English
Weight
381 KB
Volume
32
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of infliximab therapy on abdomin
Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease
✍ Erika Parmentier-Decrucq; Alain Duhamel; Olivier Ernst; Catherine Fermont; Alexa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Background: Tumor necrosis factor is an adipocytokine possessing a well-established lipolytic effect. in crohn's disease (cd) patients, infliximab therapy may thus result in visceral fat accumulation, which is associated with an increased risk of metabolic syndrome. ## Methods: A total of 132

Predictive model for the outcome of infl
Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors
✍ Tibor Hlavaty; Marc Ferrante; Liesbet Henckaerts; Marie Pierik; Paul Rutgeerts; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Background: Infliximab (ifx) is an effective therapy for refractory luminal and fistulizing crohn's disease (cd). predictors of response could improve selection of patients with a higher probability of favorable outcomes and could improve the safety profile. we aimed to develop a predictive mode